Japan To Cut Leqembi Price By 15% Following Cost Effectiveness Review

Industry Groups Call For Changes

 
• By Lisa Takagi
  
Japan's CEA Scheme
Japan's CEA Scheme going through own assessment as it leads to price cuts for more new drugs including Leqembi.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Health Technology Assessment

More from Japan